Circulating clonotypic B cells in classic Hodgkin lymphoma
about
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpointsClinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewHeterogeneity and targeting of pancreatic cancer stem cellsCustomized targeted therapy in Hodgkin lymphoma: hype or hope?Cancer stem cells: relevance to clinical transplantationAdvances in the treatment of relapsed or refractory Hodgkin's lymphomaResveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transitionSelf-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Lymphoma stem cells: enough evidence to support their existence?Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinomaTumor-associated macrophages and survival in classic Hodgkin's lymphoma.Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.Mantle cell lymphoma activation enhances bortezomib sensitivity.Characterization of chronic myeloid leukemia stem cells.Cancer stem cells: controversies in multiple myelomaPrognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.EBV in Hodgkin Lymphoma.Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.The molecular pathogenesis of Hodgkin lymphoma.Hodgkin lymphoma.Isolation of stem cells from human pancreatic cancer xenograftsLMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.A Multi-Component Model of Hodgkin's Lymphoma.Lymphoma stem cells: A step toward a new therapeutic target.Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphomaPhase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialHigh-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomasHeterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Three-dimensional Telomere Signatures of Hodgkin- and Reed-Sternberg Cells at Diagnosis Identify Patients with Poor Response to Conventional ChemotherapyChemotherapy curable malignancies and cancer stem cells: a biological review and hypothesisSmall and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.Concise review: Cancer stem cells and minimal residual diseaseTreatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphomaA tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphomaALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.
P2860
Q26745842-81C49268-09E5-434A-9047-016A6C04691CQ26770716-984E0CCB-FD5A-4E81-AEDB-BA9B3DBAC823Q26851734-4C883992-06F3-44C0-87B3-CFFD10C681B6Q27002554-25C493E7-AF19-4A2C-9A4E-9299FBBD139BQ27008959-C41508BB-76C8-4A80-ABC7-C82A7683CB56Q27694504-85231952-EF61-4FA6-A73A-95C8BCED237CQ28477031-F7E6C7F4-67A9-4CAE-B05C-A97F096714E9Q28743931-E25EE60F-F797-475D-9575-7C8C12752E6AQ30449589-12F318CB-5B3D-41CD-B7DB-76F7D7C8E0B5Q33632266-5BFF9D38-46C4-468F-B44F-8819F4D89487Q33698761-41BB9FBA-9110-443C-AAAE-F9827173CED3Q33962334-99611A01-3D56-4977-83DF-B944E4148673Q34306214-D83B0F5F-CEE8-45D7-91FC-D568A331007CQ34358461-F8A63799-A616-4AE5-91D8-A01239144798Q34360347-EB43E048-1460-4ADF-83C1-ECB90C936070Q34443802-334D8BAA-72BB-4A34-AB28-59EC04A0916FQ34462722-2A89D455-7346-4B63-875F-2312A378AF59Q34495333-27F9B376-51F8-4C9E-81B6-B6AD5149C184Q34549468-B1237E65-5937-4540-9BAF-52969307DE5CQ34557179-80938596-CAB3-4E4A-9A2C-DCDA353741A9Q34584171-66A8ED09-FA1B-407D-B81E-61C3280372D8Q34626576-EF0D3C01-4853-431A-9B31-ADEFCF38E4D3Q34643277-4C46A58D-7F36-4C54-9EC9-0E0F11FD3687Q35169948-CBD9CE7D-0804-4BB1-8AFD-68C4527341D7Q35539719-778B23EE-26D9-4E83-B9EE-1E4EE4B87164Q35615085-0CF711D8-D715-4558-A591-B32182F7F98EQ35676022-37EBD24F-5CC6-4D35-BB08-39ED61228D99Q35705317-8470EC04-6F9A-42B0-B1DE-08147AC5EB2EQ35986609-54661968-E388-4B9B-B9D9-FAA7A381C12DQ36028412-D79B6862-F3CB-4E0D-81F1-40897E2CC9EBQ36077893-C273FD29-2FC6-49B5-BEF4-EDF55DDDB73EQ36165598-292B403A-4F63-4892-AC8A-4F5DD0BD0D09Q36199852-5856BF2E-D17F-4DDE-B253-1E96FC0C8955Q36200232-FAC6A46A-EB20-4DC0-8EF3-E383270811EDQ36372097-F7644E72-28E0-4F83-BBA2-4433D192A858Q36388394-DAE32D5E-C87B-4834-8F87-4C1CAADCD492Q36671605-0E986E47-3182-497B-AFD1-284DB5854ECDQ37193976-BED14A2F-62D3-46DC-9E3D-AA310B4F106CQ37229779-60DB8811-D530-46B4-9233-08F95B31EA8DQ37716643-13C96494-D0AF-4DDA-9500-3A28D650C389
P2860
Circulating clonotypic B cells in classic Hodgkin lymphoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating clonotypic B cells in classic Hodgkin lymphoma
@en
Circulating clonotypic B cells in classic Hodgkin lymphoma.
@nl
type
label
Circulating clonotypic B cells in classic Hodgkin lymphoma
@en
Circulating clonotypic B cells in classic Hodgkin lymphoma.
@nl
prefLabel
Circulating clonotypic B cells in classic Hodgkin lymphoma
@en
Circulating clonotypic B cells in classic Hodgkin lymphoma.
@nl
P2093
P2860
P1433
P1476
Circulating clonotypic B cells in classic Hodgkin lymphoma
@en
P2093
Brandy Perkins
Carole B Miller
Christopher D Gocke
James P Barber
Jonathan M Gerber
Lan L Gellert
M Victor Lemas
Mark Siedner
Milada S Vala
Richard F Ambinder
P2860
P304
P356
10.1182/BLOOD-2008-11-189688
P407
P577
2009-02-02T00:00:00Z